Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval exchanges : Nasdaq save search
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Crawled : 00:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
| Email alert
Add to watchlist
ALPMF | News | $9.75 43.47% 200
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
| Email alert
Add to watchlist
granted approval cancer treatment for
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
DAWN S | $16.65 8.26% 7.63% 6.6M
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
day fda approval tumor for
Aemetis to Present to Institutional Investors at UBS, JP Morgan and Stifel Conferences to Review Recent Federal Approval of $200 Million of EB-5 Funding for SAF, Biogas, and CCS Projects
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
AMTX | $3.89 7.31% 6.81% 1.2M
|
Process Industries
|
| O: -1.3%
H: 2.9%
C: 2.9%
approval review million for funding
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
Published: 2024-04-23 (Crawled : 12:00) - biospace.com/
BGNE | $139.22 6.32% 5.95% 200K
|
Health Technology
|
| O: 3.5%
H: 4.77%
C: 2.39%
lung approval cancer cell treatment for
Todays' Top-5
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Published: 2024-04-23 (Crawled : 07:00) - biospace.com/
IBRX | $5.48 10.93% 9.85% 31M
|
Manufacturing
|
| O: 16.59%
H: 0.65%
C: -10.73%
il-15 anktiva fda agonist approval bladder cancer for
Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
Published: 2024-04-22 (Crawled : 18:00) - biospace.com/
LTRN | News | $5.8 1.4% 1.38% 130K
|
Health Technology
|
| O: 6.74%
H: 5.26%
C: 0.35%
lung pharma japan approval cancer cell for trial
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
SBFM | $1.235 -14.24% -22.03% 5.9M
|
Professional, Scientific, and T...
|
| O: -65.59%
H: 4.7%
C: -24.79%
pharma biosimilar health approval for canada
ContextLogic Announces Stockholder Approval of Transaction with Qoo10
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
WISH | $5.99 2.22% 2.17% 690K
|
|
| O: 16.65%
H: 5.08%
C: 2.28%
approval
Glacier Bancorp, Inc. Receives Regulatory Approval for Acquisition of Six Montana Branches From HTLF Bank
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
HTLF | $35.9 2.37% 2.31% 250K
|
Finance
|
| O: 0.09%
H: 4.5%
C: 4.47%
GBCI | $38.39 1.86% 0.0% 570K
|
Finance
|
| O: -0.48%
H: 6.27%
C: 5.78%
FRBA | News | $12.31 -1.44% -1.46% 40K
|
Finance
|
| O: 0.0%
H: 0.0%
C: 0.0%
six approval acquisition for
Terran Biosciences Granted US Patent for the World’s First New Forms of MDMA, Potentially Clearing the Path to a Future 505(b)(2) Approval
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
first patent granted approval for
Foresight Granted Patent Approval in Japan for All-Weather and Lighting Conditions Vision System
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
FRSX | $1.07 4.9% 4.67% 29K
|
Finance
|
| O: 0.0%
H: 1.74%
C: -0.87%
patent japan granted approval system vision for
Elys BMG Group Announces Approval for The Ugly Mug Sportsbook in Washington, DC.
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ELYS | $0.134 14.4% 3.9K
|
Consumer Services
| Email alert
Add to watchlist
approval group for
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
Published: 2024-04-17 (Crawled : 09:00) - globenewswire.com
BCRX | News | $4.375 -0.79% -0.8% 4.2M
|
Health Technology
|
| O: 2.97%
H: 0.0%
C: 0.0%
orladeyo health approval
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
stelara fda biosimilar approval teva
Provident Financial Services, Inc. Receives Federal Reserve Board Approval for its Merger with Lakeland Bancorp, Inc.
Published: 2024-04-11 (Crawled : 23:00) - globenewswire.com
PFS | $15.52 2.11% 0.0% 940K
|
Finance
|
| O: 1.18%
H: 3.5%
C: 2.4%
LBAI | $12.86 2.06% 2.02% 420K
|
Finance
|
| O: 0.36%
H: 4.91%
C: 3.84%
reserve approval for financial
Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Published: 2024-04-11 (Crawled : 17:00) - biospace.com/
KPRX | $0.601 23.92% 19.3% 1.2M
|
Manufacturing
|
| O: 3.23%
H: 0.16%
C: -1.79%
granted approval pharmaceuticals research for grant trial foundation study
BBSI Announces Board Approval of Planned Four-For-One Stock Split, Pending Stockholder Approval of an Increase in Authorized Shares of Common Stock
Published: 2024-04-10 (Crawled : 20:00) - globenewswire.com
BBSI | $123.47 0.54% 0.53% 17K
|
Commercial Services
|
| O: 0.93%
H: 0.0%
C: -0.7%
authorized approval
Japanese Ministry of Agriculture Grants New Approval for Broccoli Solutions
Published: 2024-04-10 (Crawled : 17:00) - agrofresh.com
PSMMY | $32.98 -1.02% 8.7K
|
Construction
|
| O: -0.67%
H: 0.0%
C: -1.77%
approval solutions for agriculture grants
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400—Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.24 0.0% 6.9M
|
Health Technology
|
| O: 2.92%
H: 3.41%
C: 2.27%
ocu400 approval positive for therapy
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
VVOS | $2.64 -1.12% 35K
|
Health Technology
|
| O: -0.33%
H: 13.91%
C: -8.77%
approval care for medical
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.